[336] Bartram, T., 1998. Bartram's encyclopedia of herbal medicine . Robinson publishing. [337] Campbell, T. C. and Campbell, T. M., 2006. The China Study . Benbella Books. [338] Ðåéêè – âèä êîìïëåìåíòàðíîé ìåäèöèíû, â êîòîðîì èñïîëüçóåòñÿ òåõíèêà òàê íàçûâàåìîãî èñöåëåíèÿ ïóòåì íàëîæåíèÿ ðóê. – Ïðèìå÷. ðåä. [339] Greenwald, Peter, 2002. Cancer chemoprevention. BMJ , 324, 714–718. [340] Clarke, M.F. and Becker, M.W., 2006. Stem cells: the real culprits in cancer? Scientific American , July 2006, 53–59. [341] Study reveals how growth factors affect human stem cells. www.hhmi.org/news/melton.hmtl [342] Murray, R.K., Granner, D.K., Mayes, P.A. and Rodwell, V.W., 1990. Harper's Biochemistry . Appleton and Lange Norwalk, CT, p. 653. [343] Woolf, Neville, 1998. Pathology, Basic and Systemic . W.B. Saunders Publishing Co., Chapter 28, p. 274, Figure 28. [344] www.intouchlive.com/cancergenetics/onco.htm [345] Ludwig, T., Fisher, P., Ganesan, S. and Efstratiadis, 2001. Tumorigenesis in mice carrying a truncating BRCA1 mutation. Genes and Development , Vol. 15 (10), 1188–1193. [346] Xu, X., Wagner, K.U., Larson, D., Weaver, Z., Li, C., Ried, T., Hennighausen, L., Wynshaw-Boris, A. and Deng, C.X. 1999. Conditional mutation of BRCA1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nature Genetics , Vol. 22 (1), 37–43. [347] Paull, T.T, Cortez, D., Bowers, B., Elledge, S.J. and Gellert, M., 2001. Direct DNA binding by BRCA1. Proceedings of the National Academy of Sciences of the USA , Vol. 98 (11), 6086–6091. [348] Jensen, R.A., Thompson, M.E., Jetton, T.L., Szabo, C.I., van der Meer, R., Helou, B., Tronick, S., King, M.C., Page, D.L. and Holt, J.T., 1996. BRCA1 is secreted and exhibits properties of a granin. Nature Genetics , 12, 303–308; www.mc.vanderbilt.edu/cancer/research/roster/jensen.html [349] Struewing, J.P., Abeliovich, D., Peretz, T., Avishai, N., Kaback, M.M., Collins, F.S. and Brody, L.C., 1995. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi-Jewish individuals. Nature Genetics , 11, 198–200; http://rex.nci.nih.gov/massmedia/back-grounders/ashkenazi.html [350] Roa, B.B., Boyd, A.A., Volcik, K. and Richards, C.S., 1996. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nature Genetics , 14, 185–187; Oddoux, C., Struewing, J.P., Clayton, C.M., Neuhausen, S., Vrody, L.C., Kaback, M., Haas, B., Norton, L., Borgen, P. Jhanwar, S., Golgar, D., Ostrer, H. and Offit, K., 1996. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1 %. Nature Genetics , 14, 188–190; http://rex.nci.nih.gov/massmedia/backgrounders/ashkenazi.html — 356 —
|